Manufacturers of hearing aids, Acacia enter settlement and patent license agreements

Download PDF Copy

May 29 2012

NewsGuard 100/100 Score

Acacia Research Corporation (Nasdaq: ACTG) announced today that its Adaptive Sonics LLC subsidiary has entered into settlement and patent license agreements with manufacturers of hearing aids.

The settlement agreements resolve litigation that was pending in the United States District Court for the Eastern District of Texas.

Source:

ACACIA RESEARCH CORPORATION

Posted in: Device / Technology News | Medical Patent News

Tags: AIDS, Hearing, Research

Comments (0)

Download PDF Copy

Suggested Reading

COVID-19 linked to increased risk of hearing loss in young adults, study finds

COVID-19 linked to increased risk of hearing loss in young adults, study finds

Dietitians boost GLP-1 therapy success with personalized care and side effect management

Dietitians boost GLP-1 therapy success with personalized care and side effect management

Older brains adapt to recognize music by reconfiguring neural activity

Older brains adapt to recognize music by reconfiguring neural activity

World Lung Day 2024: Bedfont® Scientific Limited. Leads the Way in Asthma Care with the NObreath® FeNO Device

World Lung Day 2024: Bedfont® Scientific Limited. Leads the Way in Asthma Care with the NObreath® FeNO Device

Tinnitus linked to obesity and body composition in men, study finds

Tinnitus linked to obesity and body composition in men, study finds

Neanderthal child with Down syndrome reveals ancient caregiving practices

Neanderthal child with Down syndrome reveals ancient caregiving practices

Semaglutide improves heart health and reduces weight in obese patients, but with side effects

Semaglutide improves heart health and reduces weight in obese patients, but with side effects

Semaglutide reduced mortality in obese patients by lowering infection-related deaths during COVID-19 pandemic

Semaglutide reduced mortality in obese patients by lowering infection-related deaths during COVID-19 pandemic

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Sweden exceeds UNAIDS HIV goals but faces new challenges